博瑞医药

- 688166

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016 
博瑞医药(688166) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入34,013.31117,951.7591,487.7858,748.2030,493.74
营业收入34,013.31117,951.7591,487.7858,748.2030,493.74
二、营业总成本26,734.1298,032.2969,959.9246,293.4622,920.27
营业成本14,569.4152,141.4037,893.9225,834.2712,539.42
营业税金及附加157.56571.18442.06286.69139.49
销售费用1,481.196,406.904,510.402,841.611,655.65
管理费用2,854.2311,639.548,310.855,181.132,828.03
财务费用1,166.962,414.042,421.191,810.98891.92
研发费用6,504.7824,859.2216,381.5010,338.784,865.77
资产减值损失----------
公允价值变动收益-248.02-52.0025.54174.2533.47
投资收益-454.59-1,474.11-823.78-480.65-155.24
其中:对联营企业和合营企业的投资收益-341.49-1,360.55-749.86-464.68--
汇兑收益----------
三、营业利润7,069.1719,024.4419,795.6511,354.367,560.56
加:营业外收入0.6319.9019.461.140.00
减:营业外支出11.11167.3346.2827.84--
其中:非流动资产处置损失----------
四、利润总额7,058.7018,877.0119,768.8311,327.667,560.56
减:所得税费用877.711,534.642,094.761,488.70956.10
五、净利润6,180.9817,342.3617,674.079,838.956,604.46
归属于母公司所有者的净利润6,406.9920,246.6019,179.0710,944.047,076.95
少数股东损益-226.01-2,904.24-1,505.00-1,105.08-472.49
六、每股收益
基本每股收益(元/股)0.15000.48000.45000.26000.1700
稀释每股收益(元/股)0.15000.48000.45000.26000.1700
七、其他综合收益-228.51-2,639.95-490.71-405.55--
八、综合收益总额5,952.4714,702.4217,183.369,433.416,604.46
归属于母公司所有者的综合收益总额6,178.4817,606.6518,688.3610,538.497,076.95
归属于少数股东的综合收益总额-226.01-2,904.24-1,505.00-1,105.08-472.49
下载全部历史数据到excel中 返回页顶